Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286008042> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4286008042 abstract "Abstract Objective: Treatment beyond progression (TBP) with immune checkpoint inhibitors (ICIs) is an evolving field due to the limitations of conventional imaging in response evaluation with ICIs. However, real-life data on the benefit of TBP is scarce, especially from the limited resource settings. Therefore, we aimed to investigate the survival benefit of TBP with ICIs in patients with advanced tumors from a limited resource setting. Methods: For this multicenter study, we included 282 patients treated with ICIs and radiological progression according to RECIST 1.1 criteria. The evaluated post-progression survival according to the use of TBP (TBP and non-TBP groups) with univariate and multivariate analyses. Results: 82 (29.1%) of 282 patients continued on ICIs following the initial progression event. In multivariate analyses, patients in the TBP group had improved post-progression survival compared to non-TBP (13.18 vs. 4.63 months, HR: 0.500, 95% CI: 0.349-0.717, p<0.001). The benefit of the TBP was independent of the tumor type, treatment line, and patient age. Furthermore, TBP with ICIs was associated with improved post-progression survival (HR: 0.600, 95% CI: 0.380-0.947, p=0.028) in the additional analyses after excluding the patients with no further treatment after progression in the non-TBP arm. Conclusions: In this study, we observed that patients receiving ICIs beyond progression had considerably longer survival. Continuation of ICIs after progression should be kept in mind as a reasonable management option for patients with advanced cancer, specifically for patients with limited alternative options." @default.
- W4286008042 created "2022-07-21" @default.
- W4286008042 creator A5010059818 @default.
- W4286008042 creator A5024100954 @default.
- W4286008042 creator A5032325513 @default.
- W4286008042 creator A5033323622 @default.
- W4286008042 creator A5050063396 @default.
- W4286008042 creator A5052748672 @default.
- W4286008042 creator A5053670045 @default.
- W4286008042 creator A5056813216 @default.
- W4286008042 creator A5067436525 @default.
- W4286008042 creator A5076720762 @default.
- W4286008042 creator A5083927273 @default.
- W4286008042 date "2022-07-20" @default.
- W4286008042 modified "2023-10-17" @default.
- W4286008042 title "The benefit of treatment beyond progression with immune checkpoint inhibitors: A multi- center study" @default.
- W4286008042 doi "https://doi.org/10.21203/rs.3.rs-1867719/v1" @default.
- W4286008042 hasPublicationYear "2022" @default.
- W4286008042 type Work @default.
- W4286008042 citedByCount "0" @default.
- W4286008042 crossrefType "posted-content" @default.
- W4286008042 hasAuthorship W4286008042A5010059818 @default.
- W4286008042 hasAuthorship W4286008042A5024100954 @default.
- W4286008042 hasAuthorship W4286008042A5032325513 @default.
- W4286008042 hasAuthorship W4286008042A5033323622 @default.
- W4286008042 hasAuthorship W4286008042A5050063396 @default.
- W4286008042 hasAuthorship W4286008042A5052748672 @default.
- W4286008042 hasAuthorship W4286008042A5053670045 @default.
- W4286008042 hasAuthorship W4286008042A5056813216 @default.
- W4286008042 hasAuthorship W4286008042A5067436525 @default.
- W4286008042 hasAuthorship W4286008042A5076720762 @default.
- W4286008042 hasAuthorship W4286008042A5083927273 @default.
- W4286008042 hasBestOaLocation W42860080421 @default.
- W4286008042 hasConcept C121608353 @default.
- W4286008042 hasConcept C126322002 @default.
- W4286008042 hasConcept C143998085 @default.
- W4286008042 hasConcept C2779256057 @default.
- W4286008042 hasConcept C2780739268 @default.
- W4286008042 hasConcept C3019894029 @default.
- W4286008042 hasConcept C38180746 @default.
- W4286008042 hasConcept C71924100 @default.
- W4286008042 hasConceptScore W4286008042C121608353 @default.
- W4286008042 hasConceptScore W4286008042C126322002 @default.
- W4286008042 hasConceptScore W4286008042C143998085 @default.
- W4286008042 hasConceptScore W4286008042C2779256057 @default.
- W4286008042 hasConceptScore W4286008042C2780739268 @default.
- W4286008042 hasConceptScore W4286008042C3019894029 @default.
- W4286008042 hasConceptScore W4286008042C38180746 @default.
- W4286008042 hasConceptScore W4286008042C71924100 @default.
- W4286008042 hasLocation W42860080421 @default.
- W4286008042 hasOpenAccess W4286008042 @default.
- W4286008042 hasPrimaryLocation W42860080421 @default.
- W4286008042 hasRelatedWork W2022395901 @default.
- W4286008042 hasRelatedWork W2140486815 @default.
- W4286008042 hasRelatedWork W2336461411 @default.
- W4286008042 hasRelatedWork W2891682414 @default.
- W4286008042 hasRelatedWork W2952446770 @default.
- W4286008042 hasRelatedWork W3083183993 @default.
- W4286008042 hasRelatedWork W3095421467 @default.
- W4286008042 hasRelatedWork W3134635137 @default.
- W4286008042 hasRelatedWork W3135597474 @default.
- W4286008042 hasRelatedWork W4283643050 @default.
- W4286008042 isParatext "false" @default.
- W4286008042 isRetracted "false" @default.
- W4286008042 workType "article" @default.